The primary focus of Dr. Montelaro’s research is to design and evaluate strategies to diagnose, prevent and treat retroviral infections. His specific research interests include HIV-1 and animal lentivirus such as simian immunodeficiency virus in monkeys and equine infectious anemia virus in horses. He has produced pioneering discoveries of how lentiviruses persist despite strong host immune responses and how these viruses escape vaccine immunity.
A major goal of Dr. Montelaro’s current research is to better understand the critical immune system responses that protect and control or enhance lentivirus infections and to use this information to design and evaluate possible AIDS vaccine strategies. In addition to these immunologic studies, a second major component of his research program is identifying novel targets for antiviral drug development. The third major research focus is the development of engineered antimicrobial peptides to treat bacterial and viral infections, including those caused by multidrug resistant pathogens.
Dr. Montelaro received his doctorate in biochemistry from the University of Wisconsin. He is on the editorial boards of several journals, including Virology, the Journal of Virology, AIDS and Current HIV Research. He has published more than 200 articles in the scientific literature and holds 22 patents.